BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26459520)

  • 1. VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption.
    Nurmi H; Saharinen P; Zarkada G; Zheng W; Robciuc MR; Alitalo K
    EMBO Mol Med; 2015 Nov; 7(11):1418-25. PubMed ID: 26459520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.
    Haiko P; Makinen T; Keskitalo S; Taipale J; Karkkainen MJ; Baldwin ME; Stacker SA; Achen MG; Alitalo K
    Mol Cell Biol; 2008 Aug; 28(15):4843-50. PubMed ID: 18519586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of RAMP1 Signaling Enhances Diet-induced Obesity and Fat Absorption
    Hosono K; Yamashita A; Tanabe M; Ito Y; Majima M; Tsujikawa K; Amano H
    In Vivo; 2024; 38(1):160-173. PubMed ID: 38148085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
    Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
    Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
    J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenic growth factors, receptors and therapies.
    Lohela M; Saaristo A; Veikkola T; Alitalo K
    Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lacteal integrity and junction transformation in obesity: A promising therapeutic target?
    Xia Q; Dong H; Guo Y; Fang K; Hu M; Xu L; Lu F; Gong J
    Front Endocrinol (Lausanne); 2022; 13():1007856. PubMed ID: 36506056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle.
    Kivelä R; Silvennoinen M; Lehti M; Kainulainen H; Vihko V
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2573-9. PubMed ID: 17766486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.
    Karpanen T; Wirzenius M; Mäkinen T; Veikkola T; Haisma HJ; Achen MG; Stacker SA; Pytowski B; Ylä-Herttuala S; Alitalo K
    Am J Pathol; 2006 Aug; 169(2):708-18. PubMed ID: 16877368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds.
    Hägerling R; Hoppe E; Dierkes C; Stehling M; Makinen T; Butz S; Vestweber D; Kiefer F
    EMBO J; 2018 Nov; 37(22):. PubMed ID: 30297530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer.
    Duff SE; Jeziorska M; Kumar S; Haboubi N; Sherlock D; O'Dwyer ST; Jayson GC
    Colorectal Dis; 2007 Nov; 9(9):793-800. PubMed ID: 17931169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.
    Aspelund A; Tammela T; Antila S; Nurmi H; Leppänen VM; Zarkada G; Stanczuk L; Francois M; Mäkinen T; Saharinen P; Immonen I; Alitalo K
    J Clin Invest; 2014 Sep; 124(9):3975-86. PubMed ID: 25061878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
    Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
    Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
    Blacker HA; Orgeig S
    J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.
    Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary lymphangiectasia resulting from vascular endothelial growth factor-C overexpression during a critical period.
    Yao LC; Testini C; Tvorogov D; Anisimov A; Vargas SO; Baluk P; Pytowski B; Claesson-Welsh L; Alitalo K; McDonald DM
    Circ Res; 2014 Feb; 114(5):806-22. PubMed ID: 24429550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.